Clinical Trials · NCT06173778
Semaglutide for Post-Smoking Cessation Weight Management
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- The University of Texas Health Science Center, Houston
- Enrollment
- 197
- Start date
- Apr 2024
- Locations
- 2 sites, United States
- Primary endpoint
- Change in Body Weight Percent